ClinicalTrials.Veeva

Menu

Impact of Respiratory Rehabilitation on Quality of Life in Patients With Hyperventilation Syndrome (RESPIR-HVS)

C

Centre Hospitalier Régional d'Orléans

Status

Enrolling

Conditions

Hyperventilation Syndrome

Treatments

Other: Respiratory rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT04668638
CHRO-2020-19

Details and patient eligibility

About

The hyperventilation syndrome is a quite frequent pathology, affecting up to 10% of the general population and 40% of the asthmatic population. Its physiopathology is still badly known and even if it is a benign affection, its associated comorbidities and symptomatology greatly decrease the patients' quality of life. Yet, no medicinal treatments have been proved useful, but prescribers noticed improvements after physiotherapy. Given that the physiotherapy impact on hyperventilation syndrome is not well described in the literature, this study aims to scientifically ascertain physiotherapy benefits on quality of life and symptomatology in hyperventilation syndrome-suffering patients.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Positive hyperventilation syndrome diagnosis
  • Having a social security insurance
  • Being at least 18 years old
  • Having given their written consent

Exclusion criteria

  • Being put under guardianship or curatorship
  • Having seen a physiotherapist for a respiratory rehabilitation in the last three months
  • Suffering from a chronic and degenerative pathology (chronic obstructive pulmonary disease, Parkinson's disease, idiopathic fibrosis, ...)
  • Not being able to receive the respiratory rehabilitation from our care providers
  • Already having received a rehabilitation for hyperventilation syndrome
  • Not speaking French or not being unable to complete the questionnaires

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

40 participants in 2 patient groups

Control group
Other group
Description:
Group 1 (Control Group) will not immediately receive respiratory rehabilitation but between the 2nd and 4th months postdiagnosis.
Treatment:
Other: Respiratory rehabilitation
Intervention group
Other group
Description:
Group 2 (Intervention Group) will immediately receive rehabilitation between the diagnosis and the 2nd month postdiagnosis.
Treatment:
Other: Respiratory rehabilitation

Trial contacts and locations

1

Loading...

Central trial contact

Elodie POUGOUE TOUKO; Aurélie DESPUJOLS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems